Association of the 609 C/T NAD(P)H: quinone oxidoreductase (NQO1) polymorphism with development of cutaneous malignant melanoma

Maryam Naghynajadfard, Nikolas J Hodges, Adam Towler, Amanda J Lee, Joanna Norman, Ryan Doran, Rhiannon M David, Anne E Pheasant, Jerry Marsden, James K Chipman
doi: https://doi.org/10.1101/2022.12.19.22283655

Article Information

doi 
https://doi.org/10.1101/2022.12.19.22283655
History 
  • December 19, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Maryam Naghynajadfard*,a,
  2. Nikolas J Hodgesa,
  3. Adam Towler1,a,
  4. Amanda J Lee2,a,
  5. Joanna Normana,
  6. Ryan Dorana,
  7. Rhiannon M Davida,
  8. Anne E Pheasanta,
  9. Jerry Marsden3,a and
  10. James K Chipmana
  1. aSchool of Biosciences, The University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
  1. ↵*To whom correspondence should be addressed, Email: maryam1028{at}yahoo.com, Tel: +44(0)7449862680
Back to top
Posted December 19, 2022.
Download PDF
Data/Code
Email
Association of the 609 C/T NAD(P)H: quinone oxidoreductase (NQO1) polymorphism with development of cutaneous malignant melanoma
Maryam Naghynajadfard, Nikolas J Hodges, Adam Towler, Amanda J Lee, Joanna Norman, Ryan Doran, Rhiannon M David, Anne E Pheasant, Jerry Marsden, James K Chipman
medRxiv 2022.12.19.22283655; doi: https://doi.org/10.1101/2022.12.19.22283655
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area